Analyst Price Targets — CTKB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 1, 2025 9:28 pm | — | Morgan Stanley | $6.00 | $5.33 | TheFly | Cytek Biosciences assumed with an Equal Weight at Morgan Stanley |
| March 4, 2025 11:30 am | — | Piper Sandler | $8.00 | $4.31 | TheFly | Cytek Biosciences price target lowered to $8 from $8.25 at Piper Sandler |
| February 2, 2025 10:51 am | Matthew Sykes | Goldman Sachs | $5.25 | $5.15 | TheFly | Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs |
| May 13, 2024 9:39 am | Dave Westenberg | Piper Sandler | $8.50 | $6.15 | StreetInsider | Cytek Biosciences Inc (CTKB) PT Lowered to $8.50 at Piper Sandler |
| August 17, 2022 9:41 pm | David Westenberg | Piper Sandler | $16.00 | $14.08 | TheFly | Cytek Biosciences price target raised to $16 from $12 at Piper Sandler |
| May 15, 2022 9:13 pm | David Westenberg | Piper Sandler | $12.00 | $9.38 | TheFly | Cytek Biosciences price target lowered to $12 from $17 at Piper Sandler |
Latest News for CTKB
Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.07 per share a year ago.
Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript
FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2025.
FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA.
FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CTKB.
U.S. House Trading
No House trades found for CTKB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.